Network-based inferring drug-disease associations from chemical, genomic and phenotype data

Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012

Volumn , Issue , 2012, Pages 137-142

  Huang, Yu Fen ^a   Yeh, Hsiang Yuan ^a   Soo, Von Wun ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

chemical structure; Drug disease association; network propagation; phenotype network; protein network

Indexed keywords

EXPERIMENTAL STUDIES; GENE EXPRESSION PROFILES; HIGH SPECIFICITY; NETWORK-BASED; PROSTATE CANCERS; PROTEIN INTERACTION; PROTEIN INTERACTION NETWORKS; PROTEIN NETWORK; TEST DATA; TOXICOGENOMICS;

GENE EXPRESSION; PROTEINS; STRUCTURE (COMPOSITION);

BIOINFORMATICS;

EID: 84872583984     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBM.2012.6392658     Document Type: Conference Paper

References (36)

1. K.L Goh, M.E. Cusick, D. Valle, B. Childs, M. Vidal and A.L. Barabasi, "The human disease network," Proc Nat! Acad Sci USA, vol. 104, no. 21, 2007, pp. 8685-90.
2. M.A. Yildirim, K.L Goh, M.E. Cusick, A.L. Barabasi, M. Vidal,"Drug-target network," Nat Biotechnol. vol. 25, no. 10, 2007, pp. 1119-26.
3. S. Suthram, J.T. Dudley, A.P. Chiang, R. Chen, T.J. Hastie and A.J. Butte, "Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets," PLoS Comput BioI, vol. 6, 2010, pp. e1000662.
4. C.J. Mattingly, M.C. Rosenstein, G.T. Colby, J.N. Forrest Jr and J.L. Boyer, "The Comparative toxicogenomics database (CTD): a resource for comparative toxicological studies," J. Exp. Zoolog. A Compo Exp. BioI, vol. 305, 2006, pp. 689-692.
5. J. Li, X. Zhu and J.Y. Chen, "Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts," PLoS Comput BioI, vol. 5,2009, pp. e1000450
6. J. Lamb, "The Connectivity Map: a new tool for biomedical research," Nat Rev Cancer, vol. 7, 2007, pp. 54-60.
7. J. Lamb, E.D. Crawford, D. Peck, J.W. Modell, LC. Blat, M.J. Wrobel, and et al., "The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease," Science, vol. 313, 2006, pp. 1929-1935.
8. A.P. Chiang and A.J. Butte, "Systematic evaluation of drug-disease relationships to identify leads for novel drug uses," Clin Phannacol Ther, vol. 86, 2009, pp. 507-510.
9. A. Gottlieb, G. Y Stein, E. Ruppin and R. Sharana, "PREDICT: a method for inferring novel drug indications with application to personalized medicine," Mol Syst BioI, vol. 7,2011, pp. 496.
10. S. Zhao and and S. Li, "A co-module approach for elucidating drugdisease associations and revealing their molecular basis," Bioinfonnatics, vol. 28, no. 7, 2012, pp. 955-61.
11. A. Hamosh, A.F. Scott, J. Amberger, C. Bocchini, D. Valle and V.A. McKusick, "Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders," Nucleic Acids Res, vol. 30,2002, pp. 52-55.
12. O. Vanunu, O. Magger, E. Ruppin, T. Shlomi and R. Sharan, "Associating Genes and Protein Complexes with Disease via Network Propagation," PLoS Comput BioI. vol. 6, no. 1,2010, pp. e1000641.
13. M.A. van Driel, J. Bruggeman, G. Vriend, H.G. Brunner and J.A. Leunissen, "A text-mining analysis of the human phenome," Eur J Hum Genet, vol. 14,2006, pp. 535-542.
14. D.S. Wishart, C. Knox, A.C. Guo, D. Cheng, S. Shrivastava, D. Tzur, B. Gautam and M. Hassanali, "DrugBank: a knowledgebase for drugs, drug actions and drug targets," Nucleic Acids Res, vol. 36, 2008, pp. D901-D906.
15. D. Weininger, "SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules," J Chern Inf Comput Sci, vol. 28, 1988, pp. 31-36.
16. C. Steinbeck, C. Hoppe, S. Kuhn, M. Floris, R. Guha and E.L. Willighagen, "Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics," Curr Phann Des, vol. 12,2006, pp. 2111-2120.
17. T. Tanimoto, Internal report: IBM Technical Report Series, November, 1957.
18. C. Prieto and J. De Las Rivas, "APID: agile protein interaction data analyzer," Nucleic Acids Research, vol. 34(Web Server issue), 2006, pp. W298-302.
19. S. Kohler, S. Bauer, D. Hom, P.N. Robinson, "Walking the interactome for prioritization of candidate disease genes," The American Journal of Human Genetics, vol. 82, no. 4, 2008, pp. 949958.
20. T.H. Hwang and R. Kuang, "A heterogeneous label propagation algorithm for disease gene discovery," Proc. of SIAM International Conference on Data Mining (SDM), 2010, pp. 583-594.
21. W. Xi, B. Zhang, Z. Chen, Y. Lu, S. Yan, W.Y. Ma and E.A. Fox, "Link fusion: a unified link analysis framework for multi-type interrelated data objects," World Wide Web Conference Series WWW, 2004, pp. 319-327.
22. G. Pinski and N. Narin, "Citation influence for journal aggregates of scientific publications: Theory, with application to the literature of physics," Information Process and Management, vol. 12, 1976, pp. 297-312.
23. D. Zhou, J. Weston, A. Gretton, O. Bousquet, and B. Scholkopf, "Learning with local and global consistency," In NIPS, vol. 16,2004, pp. 321-328.
24. K. Komurov, M.A. White and P.T. Ram1, "Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data," PLoS Comput BioI., vol. 6, no. 8, 2010, pp. e1000889.
25. J. Lapointe, C. Li, J.P. Higgins, M. van-de-Rijn, E. Bair, K. Montgomery, et al., "Gene expression profiling identifies clinically relevant subtypes of prostate cancer," In Proceedings of the National Academy of Sciences USA, vol. 101, no. 3,2004, pp. 811-816.
26. G. Sherlock, T. Hernandez-Boussard, A. Kasarskis, G. Binkley, J.C. Matese, S.S. Dwight, and et al., "The stanford micro array database," Nucleic Acids Research, vol. 29,2001, pp. 152-155.
27. R. Uslu, UA. Sanli, C. Sezgin, B. Karabulut, E. Terzioglu, S.B. Omay and E. Goker, "Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines," Clin Cancer Res., vol. 6, no. 12, 2000, pp. 4957-64.
28. H. Maeda, S. Hori, H. Nishitoh, H. Ichijo, O. Ogawa, Y. Kakehi and A. Kakizuka, "Tumor growth inhibition by arsenic trioxide (As20 3) in the orthotopic metastasis model of androgen-independent prostate cancer," Cancer Res., vol. 61, no. 14, 2001, pp. 5432-40.
29. H. Ye, L.L. Yang, Z.W. Cao, K.L. Tang and Y.X. Li, "A pathway profile-based method for drug repositioning," Chinese Science Bulletin, vol. 57, 2012.
30. Z. Saikali and G. Singh, "Doxycycline and other tetracyclines in the treatment of bone metastasis," Anticancer Drugs, vol. 14, no. 10, 2003, pp. 773-8.
31. D.P. Dearnaley, M.D. Mason, M.K. Parmar, K. Sanders and M.R. Sydes, "Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomized controlled trials," Lancet Oncol. vol. 10, no. 9,2009, pp. 872-6.
32. S.S. Joo and Y.M. Yoo, "Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer," J Pineal Res., vol. 47, no. 1, 2009, pp. 8-14.
33. B. Jung-Hynes, T.L. Schmit, S.R. Reagan-Shaw, LA. Siddiqui, H. Mukhtar and N. Ahmad, "Melatonin, a novel Sirt1 inhibitor, imparts Antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model," J Pineal Res., vol. 50, no. 2, 2011, pp.140-149.
34. Y.E. Whang, C.N. Moore, A.J. Armstrong, W.K. Rathmell, P.A. Godley, J.M. Crane, and et al., "A phase II trial of lapatinib in hormone refractory prostate cancer," J Clin Oncol, vol. 26, 2008
35. W.L. Dahut, C. Scripture, E. Posadas, L. Jain, J.L. Gulley, P.M. Arlen, and et al., "A phase II clinical trial of Sorafenib in androgenindependent prostate cancer," Clin Cancer Res., vol. 14, no. 1, 2008, pp.209-14.
36. G. Hu and P. Agarwal, "Human disease-drug network based on genomic expression profiles," PLoS ONE, vol. 4, no. 8, 2009, pp. e6536.